Literature DB >> 17270505

Simultaneous determination of irinotecan (CPT-11) and SN-38 in tissue culture media and cancer cells by high performance liquid chromatography: application to cellular metabolism and accumulation studies.

Ze-Ping Hu1, Xiao-Xia Yang, Xiao Chen, Eli Chan, Wei Duan, Shu-Feng Zhou.   

Abstract

A simple and sensitive HPLC method was developed to simultaneously determine CPT-11 and its major metabolite SN-38 in culture media and cell lysates. Camptothecin (CPT) was used as internal standard (I.S.). Compounds were eluted with acetonitrile-50 mM disodium hydrogen phosphate buffer containing 10 mM sodium 1-heptane-sulfonate, with the pH adjusted to 3.0 using 85% (w/v) orthophosphoric acid (27/73, v/v) by a Hyperclon ODS (C18) column (200 mm x 4.6 mm i.d.), with detection at excitation and emission wavelengths of 380 and 540 nm, respectively. The average extraction efficiencies were 96.9-108.3% for CPT-11 in culture media and 94.3-107.2% for CPT-11 in cell lysates; and 87.7-106.8% for SN-38 in culture media and 90.1-105.6% for SN-38 in cell lysates. Within- and between-day precision and accuracy varied from 0.1 to 10.3%. The limit of quantitation (precision and accuracy <20%) was 5.0 and 2.0 ng/ml for CPT-11 and 1.0 and 0.5 ng/ml for SN-38 in culture media and cell lysates, respectively. This method was successfully applied to quantitate the cellular accumulation and metabolism of CPT-11 and SN-38 in H4-II-E, a rat hepatoma cell line.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17270505     DOI: 10.1016/j.jchromb.2006.12.056

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Canine spontaneous glioma: a translational model system for convection-enhanced delivery.

Authors:  Peter J Dickinson; Richard A LeCouteur; Robert J Higgins; John R Bringas; Richard F Larson; Yoji Yamashita; Michal T Krauze; John Forsayeth; Charles O Noble; Daryl C Drummond; Dmitri B Kirpotin; John W Park; Mitchel S Berger; Krystof S Bankiewicz
Journal:  Neuro Oncol       Date:  2010-05-20       Impact factor: 12.300

2.  Development and validation of an UPLC-MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: Application to a pharmacokinetic study of irinotecan in rats.

Authors:  Sumit Basu; Min Zeng; Taijun Yin; Song Gao; Ming Hu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-02-09       Impact factor: 3.205

3.  Quantitative determination of irinotecan and the metabolite SN-38 by nanoflow liquid chromatography-tandem mass spectrometry in different regions of multicellular tumor spheroids.

Authors:  Xin Liu; Amanda B Hummon
Journal:  J Am Soc Mass Spectrom       Date:  2015-01-21       Impact factor: 3.109

4.  The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors.

Authors:  Brian S Choi; Dona B Alberti; William R Schelman; Jill M Kolesar; James P Thomas; Rebecca Marnocha; Jens C Eickhoff; S Percy Ivy; George Wilding; Kyle D Holen
Journal:  Cancer Chemother Pharmacol       Date:  2010-02-02       Impact factor: 3.333

5.  Intracellular dynamics of topoisomerase I inhibitor, CPT-11, by slit-scanning confocal Raman microscopy.

Authors:  Yoshinori Harada; Ping Dai; Yoshihisa Yamaoka; Mitsugu Ogawa; Hideo Tanaka; Kazuto Nosaka; Kenichi Akaji; Tetsuro Takamatsu
Journal:  Histochem Cell Biol       Date:  2009-04-14       Impact factor: 4.304

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.